CycloSam Therapeutics is Biotechnology in United States that focus on reduced myelotoxicity business. Founded in 2016. They cover business area such as developer, a bone, agent, metastatic bone cancer, delivery, high amount, radioactivity, bone marrow suppression, treatment, osteosarcoma, relief, pain, bone metastasis, reduce myelotoxicity, patient.
2016
( 8 years old in 2024 )
Reduced Myelotoxicity
-
1004 South Velasco Street
Angleton, TX 77515
United States
Private
developera boneagentmetastatic bone cancerdeliveryhigh amountradioactivitybone marrow suppressiontreatmentosteosarcomareliefpainbone metastasisreduce myelotoxicitypatient
* We use standard office opening hours in near CycloSam Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
CycloSam Therapeutics is Biotechnology business from United States that founded in 2016 (8 years old in 2024), CycloSam Therapeutics business is focusing on Reduced Myelotoxicity.
CycloSam Therapeutics headquarter office and corporate office address is located in 1004 South Velasco Street Angleton, TX 77515 United States.
CycloSam Therapeutics was founded in United States.
In 2024, CycloSam Therapeutics is currently focus on reduced myelotoxicity sector.
Above is snippet of Google Trends for "reduced myelotoxicity" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with CycloSam Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
